4//SEC Filing
WILLIAMS FRANK J 4
Accession 0001628908-23-000072
CIK 0001628908other
Filed
Jun 4, 8:00 PM ET
Accepted
Jun 5, 4:23 PM ET
Size
19.6 KB
Accession
0001628908-23-000072
Insider Transaction Report
Form 4
WILLIAMS FRANK J
DirectorChief Executive Officer
Transactions
- Exercise/Conversion
Class A Common Stock
2023-06-01$6.87/sh+19,060$130,942→ 838,872 total - Exercise/Conversion
Class A Common Stock
2023-06-01$10.27/sh+90,940$933,954→ 929,812 total - Sale
Class A Common Stock
2023-06-01$29.74/sh−49,026$1,458,033→ 819,812 total - Exercise/Conversion
Class A Common Option (right to buy)
2023-06-01−19,060→ 0 totalExercise: $6.87Exp: 2025-02-01→ Class A Common Stock (19,060 underlying) - Sale
Class A Common Stock
2023-06-01$29.27/sh−9,091$266,094→ 920,721 total - Sale
Class A Common Stock
2023-06-01$29.75/sh−9,969$296,578→ 910,752 total - Sale
Class A Common Stock
2023-06-01$29.26/sh−41,914$1,226,404→ 868,838 total - Exercise/Conversion
Class A Common Option (right to buy)
2023-06-01−90,940→ 17,250 totalExercise: $10.27Exp: 2026-03-01→ Class A Common Stock (90,940 underlying)
Holdings
- 66,064(indirect: See footnote)
Class A Common Stock
Footnotes (9)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 26, 2022.
- [F2]Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.63 to $29.62, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.63 to $29.83, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F5]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.60 to $29.59, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F6]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.60 to $29.86, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F7]Shares held of record by the Frank Williams Irrevocable Trust. Mr. Williams serves as the Trustee of the Frank Williams Irrevocable Trust.
- [F8]The Class A Common Stock Options exercised vested on February 1, 2019.
- [F9]The Class A Common Stock Options exercised vested on March 1, 2017, March 1, 2018, March 1, 2019, and March 1, 2020.
Documents
Issuer
Evolent Health, Inc.
CIK 0001628908
Entity typeother
Related Parties
1- filerCIK 0001204938
Filing Metadata
- Form type
- 4
- Filed
- Jun 4, 8:00 PM ET
- Accepted
- Jun 5, 4:23 PM ET
- Size
- 19.6 KB